Frequency of Class I Anti HLA Alloantibodies in Patients Infected by HIV 1

The aim of this study was to evaluate the presence of class I anti-HLA alloantibodies in patients infected by HIV-1 and relate it with the different clinical courses of the disease. Blood samples were collected in EDTA tubes from 145 individuals. HIV-1 infection was confirmed by ELISA test. The pres...

ver descrição completa

Detalhes bibliográficos
Autores: Leite, Elza Regina Manzolli, Lima, Oswaldo Luiz Luz, Leite, Fábio Renato Manzolli, Costa, Paulo Inácio da
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2010
País:Brasil
Recursos:Universidade Federal de Pelotas (UFPEL)
Repositorio:Repositório Institucional da UFPel - Guaiaca
Idioma:inglés
OAI Identifier:oai:guaiaca.ufpel.edu.br:123456789/852
Acesso em linha:https://guaiaca.ufpel.edu.br/handle/123456789/852
Access Level:acceso abierto
Palavra-chave:AIDS
HIV
HLA antigens
Alloantibodies
Descrição
Resumo:The aim of this study was to evaluate the presence of class I anti-HLA alloantibodies in patients infected by HIV-1 and relate it with the different clinical courses of the disease. Blood samples were collected in EDTA tubes from 145 individuals. HIV-1 infection was confirmed by ELISA test. The presence of class I anti-HLA alloantibodies and HLA allele’s were determined. Clinical evolution was set as fast (<1 year between diagnostic and death), moderate (1-3 years) or slow (>3 years). Class I anti-HLA alloantibodies presence was lower in healthy individuals than in those infected by HIV-1 (4.2% against 32.4%). However, an equal distribution of these alloantibodies was found among the individuals infected, independent on the clinical evolution. Thus, class I anti-HLA alloantibodies was not a determinant factor for patient worsening.